MyFinsight
Home
Blog
About
Net earnings
$3,616M
(284.27%↑ Y/Y)
Amortization of intangible
assets
$1,689M
(-9.39%↓ Y/Y)
Change in fair value of
contingent consideration...
$1,518M
(-45.69%↓ Y/Y)
Accounts payable and
other liabilities
$1,202M
(133.40%↑ Y/Y)
Acquired ipr&d and
milestones
$291M
(-64.64%↓ Y/Y)
Depreciation
$194M
(4.30%↑ Y/Y)
Stock-based compensation
$166M
(-7.26%↓ Y/Y)
Other, net
-$4M
(94.94%↑ Y/Y)
Cash flows from
operating activities
$3,436M
(-33.32%↓ Y/Y)
Canceled cashflow
$5,244M
Net change in cash
and equivalents
-$2,822M
(-318.42%↓ Y/Y)
Canceled cashflow
$3,436M
Other, net
$25M
(2400.00%↑ Y/Y)
Income tax assets and
liabilities, net
-$2,223M
(-61.67%↓ Y/Y)
Accounts receivable
$1,369M
(7952.94%↑ Y/Y)
Payments of contingent
consideration liabilities
$1,062M
(23.63%↑ Y/Y)
Deferred income taxes
-$195M
(28.31%↑ Y/Y)
Prepaid expenses and
other assets
$188M
(150.67%↑ Y/Y)
Inventories
$143M
(155.36%↑ Y/Y)
Non-cash litigation
reserve adjustments,...
-$64M
(-204.76%↓ Y/Y)
Cash flows from
financing activities
-$5,054M
(-86.49%↓ Y/Y)
Canceled cashflow
$25M
Cash flows from
investing activities
-$1,197M
(-1.35%↓ Y/Y)
Effect of exchange rate
changes on cash and...
-$7M
(-123.33%↓ Y/Y)
Dividends paid
$3,070M
(5.50%↑ Y/Y)
Repayments of long-term
debt
$2,000M
(-46.72%↓ Y/Y)
Purchases of treasury
stock
$9M
(-25.00%↓ Y/Y)
Other acquisitions
and investments,...
$824M
(-12.34%↓ Y/Y)
Acquisitions of property and
equipment
$322M
(19.70%↑ Y/Y)
Other, net
$51M
(254.55%↑ Y/Y)
Back
Back
Cash Flow
ABBV_BIG copy-svg
AbbVie Inc. (ABBV)
ABBV_BIG copy-svg
AbbVie Inc. (ABBV)
source: myfinsight.com